Experimental serological test to guarantee our workforce’s health and safety

Starting next week, in addition to the comprehensive measures already adopted, we will offer an experimental serological test, on a voluntary basis, to the critical workers at our plants who guarantee the main activities.

This test will allow the rapid detection of anti-SARS-CoV-2 Ig and IgM antibodies in the blood samples. As a result, more information regarding asymptomatic cases will be available in order to manage them according to health protocols. As always, our workforce’s health and safety is our priority.